Mustafa Nevzat (MN) Pharmaceuticals is one of the leading and oldest pharmaceutical companies in Turkey. The company was established in 1923 in a district of Istanbul known as Uskudar, Yhsaniye under the name of Mustafa Nevzat Laboratory. The laboratory had 8 employees and was one of the first manufacturers of injectable products in Turkey.
Currently, MN Pharmaceuticals has a trained personnel of 1090 and with its modern facilities is one of the leading manufacturers of active pharmaceutical ingredients and finished dosage forms in Turkey.
There are four separate production units of the Active Pharmaceutical Ingredients Plant - penicillin group active substances, macrolide group active substances and etodolac, and other active substances are manufactured. There are four dedicated production plants for finished dosage forms in Yenibosna, Istanbul. Penicillin-like and cephalosporin-like beta-lactam products are produced in two separate, dedicated plants.
In a separate and dedicated third plant, other groups of antibiotics, corticosteroids, cardiovascular agents, anti-inflammatory agents, gastrointestinal agents and agents belonging to other therapeutic groups are manufactured.
The newly established and the fourth finished dosage forms plant, Injectable Oncology Products Plant, has been completed at the beginning of 2009. In this plant, dosage forms in liquid and freeze-dried vials are manufactured.
"The products are manufactured according to ’Current Good Manufacturing Practices (cGMP)’ and ’Current Good Laboratory Practices (cGLP)’ and as a result of continuous training, education and modern technology," tells the company website.
LATEST issue 4/2022
Hannover Messe 2023’s lead theme ‘Industrial Transformation – Making the Difference’ will show the difference that exhibiting companies can make, which changes they can carry out and which innovations they can develop on the road to a climate-neutral industry. Learn more about the upcoming event from the latest issue 4/2022...
Romania’s Star Assembly, a fully-owned subsidiary of Mercedes-Benz, announced it will invest a nine-figure sum to extend its production portfolio and include the assembly of electric drive units for new generation Mercedes-EQ electric vehicles starting 2025...
Magna is expanding its footprint in Eastern Europe with the opening of a new facility in Struga, North Macedonia. Тhe new plant will support several European automakers. More details read in the latest issue 4/2022...